Neurocardiogenic syncope: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
mNo edit summary |
||
| Line 1: | Line 1: | ||
'''For patient information on this page, click [[Neurocardiogenic syncope (patient information)|here]]''' | |||
{{Neurocardiogenic syncope}} | {{Neurocardiogenic syncope}} | ||
{{CMG}} | {{CMG}} | ||
== | ==[[Neurocardiogenic syncope overview|Overview]]== | ||
==[[Neurocardiogenic syncope pathophysiology|Pathophysiology]]== | |||
==[[Neurocardiogenic syncope epidemiology and demographics|Epidemiology & Demographics]]== | |||
==[[Neurocardiogenic syncope risk factors|Risk Factors]]== | |||
==[[Neurocardiogenic syncope causes|Causes]]== | |||
==[[Neurocardiogenic syncope natural history|Natural History, Prognosis & Complication]]== | |||
==[[Neurocardiogenic syncope differentiating from other diseases|Differentiating Neurocardiogenic Syncope From Other Diseases]]== | |||
==Diagnosis== | |||
[[Neurocardiogenic syncope symptoms|History & Symptoms]] | [[Neurocardiogenic syncope physical examination|Physical Examination]] | [[Neurocardiogenic syncope electrocardiogram|Electrocardiogram]] | [[Neurocardiogenic syncope chest x-ray|Chest X-Ray]] | [[Neurocardiogenic syncope echocardiography|Echocardiography]] | [[Neurocardiogenic syncope cardiac catheterization|Cardiac Catheterization]] | |||
==Treatment== | |||
====[[Neurocardiogenic syncope medical treatment|Medical Therapy]]==== | |||
====[[Neurocardiogenic syncope pacemaker therapy|Pacemaker Therapy]]==== | |||
==Additional Resources== | |||
# Neurocardiogenic syncope. Carol Chen-Scarabelli, Tiziano M Scarabelli. BMJ 2004;329:336–41 | # Neurocardiogenic syncope. Carol Chen-Scarabelli, Tiziano M Scarabelli. BMJ 2004;329:336–41 | ||
# Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, et al for the Task Force on Syncope, European Society of Cardiology.Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 2001;22:1256-306. | # Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, et al for the Task Force on Syncope, European Society of Cardiology.Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 2001;22:1256-306. | ||
| Line 9: | Line 32: | ||
# Connolly SJ, Sheldon R, Thorpe KE, et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA. 2003;289:2224-9. | # Connolly SJ, Sheldon R, Thorpe KE, et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA. 2003;289:2224-9. | ||
[[Category:Disease]] | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 02:22, 17 May 2012
For patient information on this page, click here
|
Neurocardiogenic Syncope Microchapters |
|
Differentiating Neurocardiogenic Syncope From Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Neurocardiogenic syncope On the Web |
|
American Roentgen Ray Society Images of Neurocardiogenic syncope |
|
Risk calculators and risk factors for Neurocardiogenic syncope |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Pathophysiology
Epidemiology & Demographics
Risk Factors
Causes
Natural History, Prognosis & Complication
Differentiating Neurocardiogenic Syncope From Other Diseases
Diagnosis
History & Symptoms | Physical Examination | Electrocardiogram | Chest X-Ray | Echocardiography | Cardiac Catheterization
Treatment
Medical Therapy
Pacemaker Therapy
Additional Resources
- Neurocardiogenic syncope. Carol Chen-Scarabelli, Tiziano M Scarabelli. BMJ 2004;329:336–41
- Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, et al for the Task Force on Syncope, European Society of Cardiology.Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 2001;22:1256-306.
- Vasovagal Syncope. Alexis M. Fenton, MD; Stephen C. Hammill, MD; Robert F. Rea, MD; Phillip A. Low, MD; and Win-Kuang Shen, MD. Ann Intern Med. 2000;133:714-725.
- Connolly SJ, Sheldon R, Thorpe KE, et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA. 2003;289:2224-9.